{"product_id":"metformin-therapeutic-option-in-people-at-high-cardiometabolic-risk-von-petya-kamenova","title":"Metformin: therapeutic option in people at high cardiometabolic risk","description":"\u003cp\u003eThe topic of this book is prevention of type 2 diabetes mellitus and cardiovascular disease which are increasing by epidemic proportions all over the world. Metabolic syndrome is well established risk factor for type 2 diabetes mellitus and cardiovascular disease. Hyperinsulinaemia is considered as the earliest stage of development of type 2 diabetes and a core defect unifying the cardiovascular cluster of the metabolic syndrome. Treatment of the metabolic syndrome and hyperinsulinaemia is essential for the prevention of type 2 diabetes and cardiovascular disease. Metformin is a medication of first choice in therapeutic strategy of type 2 diabetes. The book comprises of two research articles representing results of metformin treatment in people at high risk for development of type 2 diabetes mellitus and cardiovascular disease such as those with hyperinsulinaemia, normal glucose tolerance and metabolic syndrome.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783659842092\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Autorenwelt Shop","offers":[{"title":"Softcover - 9783659842092","offer_id":50049355252037,"sku":"9783659842092","price":36.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/92222f63-9b43-4dc8-90d7-a43f3883d5ff.jpg?v=1769146830","url":"https:\/\/shop.autorenwelt.de\/products\/metformin-therapeutic-option-in-people-at-high-cardiometabolic-risk-von-petya-kamenova","provider":"Autorenwelt Shop","version":"1.0","type":"link"}